CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis
Xiaoli Li(Fujian Medical University), Weiying Zhou(Chongqing Medical University), Duanfang Zhou(Chongqing Medical University), Bo Chen(Chongqing Medical University), Hongfang Zeng(Chongqing University), Wenjun Li(Southern Medical University), Xiangru Zheng(First Affiliated Hospital of Chongqing Medical University), Xiaoping Yu(Tianjin University of Science and Technology), Liangyuan Long(Chongqing University)
Cited by 34
Related Papers
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
The Physiologic Role of CD19 Cytoplasmic Tyrosines
|Immunity|2002|145
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
|Current Pharmaceutical Design|2017|132
Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway
|Journal of Cellular Physiology|2019|115